NCT00076609View on ClinicalTrials.gov

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2003

Conditions
Hepatocellular CarcinomaLiver Cancer
Interventions
DRUG

PHY906

DRUG

capecitabine

Trial Locations (5)

91010

City of Hope National Medical Center, Duarte

94305

Stanford Hospital and Clinics, Stanford

06520

Yale University, New Haven

06516

VA Connecticut Cancer Center, West Haven

Unknown

National Institute of Cancer Research, Taipei

Sponsors

Lead Sponsor

PhytoCeutica
All Listed Sponsors
lead

PhytoCeutica

INDUSTRY